Mark Edward Schnute
26Patents
7h-index
63Co-inventors
72Inventor score
Filing activity: Dec 1, 1998 → May 3, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6248739A | Quinolinecarboxamides as antiviral agents | Chemistry; Metallurgy | 28 | Expired |
| US6624159B2 | Heterocycle carboxamides as antiviral agents | Human Necessities | 17 | Expired |
| US6559145B2 | Heterocycle carboxamides as antiviral agents | Chemistry; Metallurgy | 15 | Expired |
| US6852731B2 | Antiviral compounds | Human Necessities | 13 | Expired |
| US6730682B2 | Heterocycle carboxamides as antiviral agents | Chemistry; Metallurgy | 12 | Expired |
| US6093732A | 4-hydroxyquinoline-3-carboxamides and hydrazides as antiviral agents | Chemistry; Metallurgy | 8 | Expired |
| US6248736A | 4-oxo-1,4-dihydro-3-quinolinecarboxamides as antiviral agents | Human Necessities | 7 | Expired |
| US6239142A | 4-oxo-4,7-dihydro-thieno[2,3-b]pyridine-5carboxamides as antiviral agents | Chemistry; Metallurgy | 6 | Expired |
| US6653307B2 | 1-aryl-4-oxo-1,4-dihydro-3-quinolinecarboxamides as antiviral agents | Chemistry; Metallurgy | 2 | Expired |
| US10266513B2 | Bruton's tyrosine kinase inhibitors | Human Necessities | 2 | Active |
| US9670201B2 | Methyl- and trifluoromethyl-substituted pyrrolopyridine modulators of RORC2 and methods of use thereof | Performing Operations; Transporting | 2 | Active |
| US9920054B2 | Methyl- and trifluoromethyl-substituted pyrrolopyridine modulators of RORC2 and methods of use thereof | Performing Operations; Transporting | 2 | Active |
| US10975065B2 | N-substituted-dioxocyclobutenylamino-3-hydroxy-picolinamides useful as CCR6 inhibitors | Chemistry; Metallurgy | 2 | Active |
| US10336748B2 | Methyoxy-substituted pyrrolopyridine modulators of RORC2 and methods of use thereof | Human Necessities | 1 | Active |
| US10227346B2 | Methyl- and trifluoromethyl-substituted pyrrolopyridine modulators of RORC2 and methods of use therof | Performing Operations; Transporting | 1 | Active |
| US10426135B2 | Methyl- and trifluromethyl-substituted pyrrolopyridine modulators of RORC2 and methods of use thereof | Performing Operations; Transporting | 1 | Active |
| US11708360B2 | N-substituted-dioxocyclobutenylamino-3-hydroxy-picolinamides useful as CCR6 inhibitors | Chemistry; Metallurgy | 1 | Active |
| US10385036B2 | Sulfonamide-substituted indole modulators of RORC2 and methods of use thereof | Chemistry; Metallurgy | 1 | Active |
| US11655252B2 | Aminopyrimidinyl derivatives | Chemistry; Metallurgy | 0 | Active |
| US6831081B2 | 4-Oxo-4,7-dihydrothieno[2,3-b]pyridine-5-carboxamides as antiviral agents | Human Necessities | 0 | Expired |
| US6562822B2 | Heterocyle carboxamides as antiviral agents | Chemistry; Metallurgy | 0 | Expired |
| US12312344B2 | N-substituted-dioxocyclobutenylamino-3-hydroxy-picolinamides useful as CCR6 inhibitors | Chemistry; Metallurgy | 0 | Active |
| US6903097B2 | Heterocycle carboxamides as antiviral agents | Chemistry; Metallurgy | 0 | Expired |
| US6861438B2 | Antiviral agents | Human Necessities | 0 | Expired |
| US6878705B2 | 4-oxo-4,7-dihydrofuro[2,3-b]pyridine-5-carboxamide antiviral agents | Human Necessities | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.